The firm is hoping to make up for revenue lost to generic competition in coming years by growing adoption of treatments like ...

Consumers are increasingly looking beyond pills and foams. Topical serums, natural compounds, and growth-factor therapies now ...

Q1 2026 earnings call recap: raised FY26 guidance, OneOncology integration, EPS/revenue highlights, risks and outlook—read ...

Researchers studying the malaria parasite Plasmodium falciparum have discovered a previously unknown stage in its life cycle ...

Amgen Inc. (NASDAQ:AMGN) Q4 2025 Earnings Call Transcript February 3, 2026 Amgen Inc. beats earnings expectations. Reported ...

A new study finds that a trait helping a marine bacterium survive and flourish today may ultimately become its Achilles Heel as ocean conditions continue to shift.

“For many cell-based therapies, progress comes from connecting the right pieces at the right moment,” Klein said. “When ...

Common ocean bacteria struggle to divide when conditions change, reshaping how warming seas affect ecosystems.

SAR11 bacteria dominate the world’s oceans by being incredibly efficient, shedding genes to survive in nutrient-poor waters.

Cancer and Alzheimer’s disease rarely strike the same person, a pattern that has puzzled clinicians for years. Instead of ...

The FDA accepted an application for ivonescimab with chemotherapy for patients with lung cancer driven by EGFR changes after ...

A group of ocean bacteria long considered perfectly adapted to life in nutrient-poor waters may be more vulnerable to environmental change than scientists realized. The bacteria, known as SAR11, ...